<i>Toxoplasma gondii</i> effector TgIST blocks type I interferon signaling to promote infection.

Matta, Sumit K; Olias, Philipp; Huang, Zhou; Wang, Qiuling; Park, Eugene; Yokoyama, Wayne M; Sibley, L David · Proc Natl Acad Sci U S A · 2019

basic_science · Level V

Where this comes from

Abstract

In contrast to the importance of type II interferon-γ (IFN-γ) in control of toxoplasmosis, the role of type I IFN is less clear. We demonstrate here that TgIST, a secreted effector previously implicated in blocking type II IFN-γ signaling, also blocked IFN-β responses by inhibiting STAT1/STAT2-mediated transcription in infected cells. Consistent with a role for type I IFN in cell intrinsic control, ∆<i>Tgis</i>t mutants were more susceptible to growth inhibition by murine and human macrophages activated with IFN-β. Additionally, type I IFN was important for production of IFN-γ by natural killer (NK) cells and recruitment of inflammatory monocytes at the site of infection. Mice lacking type I IFN receptors (Ifnar1<sup>-/-</sup>) showed increased mortality following infection with wild-type parasites and decreased virulence of ∆Tgist parasites was restored in Ifnar1<sup>-/-</sup> mice. The findings highlight the importance of type I IFN in control of toxoplasmosis and illuminate a parasite mechanism to counteract the effects of both type I and II IFN-mediated host defenses.

Medical subject headings